GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

EvoNext Holdings EVE.SW · CHF

Materials · SIX · 🇨🇭 Switzerland

Compare

2.38

+0.85%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About EvoNext Holdings

Its shares trade on SIX under the ticker EVE.SW. It has been listed since 4 May 2005. In the fiscal year to 31 December 2023, it reported revenue of CHF 9.4m and a net loss of CHF 105.2m. At that date it held total assets of CHF 9.8m and shareholders' equity of CHF 5.6m.

Evolva Holding SA is a biotech company, which engages in the research, development, manufacture, and commercialization of nutritional, healthcare, and wellness ingredients. The company is headquartered in Reinach, Basel-Landschaft. The company went IPO on 2005-05-04. The activity of the Company is divided into two segments: technololgy platforms - combines biology with technology to produce nature-based ingredients; technology servises- provides tailored services to clients across industries. The firm is focused on developing and increase the yield and efficiency of the production of various ingredients.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Materials
Industry
Chemicals
Listed since
4 May 2005
Employees
66
Website
evolva.com ↗

Leadership

Pay as last reported

  • Mr. Stephan SchindlerNon-Executive Chairman of the BoardCHF 80,000
  • Dr. Beat In-AlbonNon-Executive DirectorCHF 40,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
11
Environment
8
Social
12
Governance
13
Carbon reduction policy
No
Human rights policy
No

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Company is headquartered in Reinach, Basel-Landschaft with 66 employees.
  • IPO took place on 2005-05-04.
  • Operates in the Materials sector within the Chemicals industry.

Weaknesses

  • Source description incorrectly identifies the company as a biotech company.
  • Source description misstates the industry as Chemicals instead of biotech.
  • Source description incorrectly describes the company's activities as research and development of ingredients.

Opportunities

  • Company has technology platforms combining biology with technology for nature-based ingredients.
  • Company provides technology services to clients across industries.
  • Focus on increasing yield and efficiency of ingredient production.

Threats

  • Source description is untrusted and contains factual errors.
  • Misclassification as a biotech company may lead to market confusion.
  • Incorrect industry description could affect investor perception.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.